ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 750,25
0,40%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. abrdn Life Sciences Investors (HQL)

  7. abrdn Life Sciences Investors (HQL) Actualités

HQL

abrdn Life Sciences Inve... (HQL)

abrdn Life Sciences Investors
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:HQL
DateHeureSourceTitreSymboleSociété
31/05/202421h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
29/05/202421h51Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NYSE:HQLabrdn Life Sciences Investors
24/05/202415h13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:HQLabrdn Life Sciences Investors
07/02/202413h55Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:HQLabrdn Life Sciences Investors
29/12/202313h54Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNYSE:HQLabrdn Life Sciences Investors
22/12/202320h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
12/12/202316h57Edgar (US Regulatory)Form N-CEN - Annual Report for Registered Investment CompaniesNYSE:HQLabrdn Life Sciences Investors
11/12/202322h11Edgar (US Regulatory)Form N-CSR - Certified Shareholder ReportNYSE:HQLabrdn Life Sciences Investors
27/10/202322h57Business WireTekla Capital Management LLC Announces Closing of Transaction With abrdnNYSE:HQLabrdn Life Sciences Investors
27/10/202322h57Business WireTekla Funds Approve New Investment Advisory Agreements With abrdn Inc.NYSE:HQLabrdn Life Sciences Investors
14/10/202300h26Business WireTekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the FundsNYSE:HQLabrdn Life Sciences Investors
05/10/202320h05Business WireTekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund ExpensesNYSE:HQLabrdn Life Sciences Investors
29/09/202316h35Business WireTekla Life Sciences Investors Paid DistributionNYSE:HQLabrdn Life Sciences Investors
27/09/202315h33Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]NYSE:HQLabrdn Life Sciences Investors
13/09/202314h51Business WireTekla Funds Announce Adjournment of Special Meetings and Implore Shareholders to Vote Their Shares ImmediatelyNYSE:HQLabrdn Life Sciences Investors
12/09/202323h06Edgar (US Regulatory)Form 8-K - Current reportNYSE:HQLabrdn Life Sciences Investors
30/08/202320h39Business WireTekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation EffortsNYSE:HQLabrdn Life Sciences Investors
25/08/202320h35Edgar (US Regulatory)Form N-CSR/A - Certified Shareholder Report: [Amend]NYSE:HQLabrdn Life Sciences Investors
15/08/202315h55Business WireTekla Life Sciences Investors Declares DistributionNYSE:HQLabrdn Life Sciences Investors
14/08/202321h10Business WireTekla Funds Announce Adjournment of Special MeetingsNYSE:HQLabrdn Life Sciences Investors
04/08/202318h05Edgar (US Regulatory)Form N-PX - Annual Report of proxy voting record of management investment companiesNYSE:HQLabrdn Life Sciences Investors
27/06/202323h07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:HQLabrdn Life Sciences Investors
20/06/202323h48Business WireTekla Capital Management LLC Announces Proposed TransactionNYSE:HQLabrdn Life Sciences Investors
15/05/202320h42Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)NYSE:HQLabrdn Life Sciences Investors
11/04/202318h13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:HQLabrdn Life Sciences Investors
31/03/202315h55Business WireTekla Healthcare Investors Paid DistributionNYSE:HQLabrdn Life Sciences Investors
31/03/202315h55Business WireTekla Healthcare Opportunities Fund Paid DistributionNYSE:HQLabrdn Life Sciences Investors
31/03/202315h55Business WireTekla World Healthcare Fund Paid DistributionNYSE:HQLabrdn Life Sciences Investors
16/03/202319h40Business WireTekla Life Sciences Investors Announce Renewal of Share Repurchase ProgramNYSE:HQLabrdn Life Sciences Investors
13/12/202219h22Edgar (US Regulatory)Annual Report for Registered Investment Companies (n-cen)NYSE:HQLabrdn Life Sciences Investors
 Showing the most relevant articles for your search:NYSE:HQL

Dernières Valeurs Consultées

BOV
EQPA6
EQTL PARA PNB
LSE
RA10
Barclays 27
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés